Mr. Barry O'Leary:

Negotiating pricing is not something in which we would be closely involved. While we would like to think we had all the pharmaceutical investment in the world in Ireland, a substantial number of companies are not here and the pricing applies equally to them regardless of whether they are in Ireland or not. The decision we are talking about is a major investment and we want to make sure that our mission is very firm on what we are out to achieve. Other people have to take on the responsibility for their particular missions.